Complaining about a smallcap biotech for the posibility of needing to raise capital at some point in the future and 'speculative being a good description' is sort of stating the obvious isn't it? Speculative is indeed what a small company without revenue is.. It sounds like some of these posters may be better off putting their money into an ETF or a nice set of multi billion $ blue chips.
Complaining about a smallcap biotech for the posibility of...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.003(6.67%) |
Mkt cap ! $57.67M | |||
| Open | High | Low | Value | Volume |
| 4.5¢ | 4.5¢ | 4.2¢ | $57.82K | 1.360M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 368290 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 133896 | 4 |
View Market Depth
| Last trade - 15.43pm 08/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |